Head-to-head · WeighScore
altRX vs AVARA Rx
The verdict
altRX takes it — 71.4/100 to 62.8/100.
altRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | altRX | AVARA Rx |
|---|---|---|
| WeighScore | 71.4/100 | 62.8/100 |
| Grade | C | C |
| Scorecard rank | #92 | #263 |
| Semaglutide | $149/mo (starting dose, compounded) | $229/mo (starting dose, compounded) |
| Tirzepatide | $249/mo (starting dose, compounded) | $279/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #92 · C
Strengths
- Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
- LegitScript Certified with a publicly verifiable seal
- Publishes the FDA compounded-medication disclaimer
- Transparent pricing across all six product tiers (compounded plus four brand-name)
- All-inclusive pricing — consult, prescription, and shipping with no hidden fees
Where it loses points
- States-served list not disclosed
- 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
- 503A vs 503B designation not specified
- No named medical director
- Corporate physical address not disclosed
Graded #263 · C
Strengths
- Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
- Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
- All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
- Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
- LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities
Where it loses points
- Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
- Dose pricing not itemized — only 'starting at $229' semaglutide and 'starting at $279' tirzepatide
- LegitScript certification number not shown — badge only, so no direct lookup
- No named medical director (Beluga Health is the network, not a named MD)
- Lab work requirements not specified, and consultation fee not broken out from medication cost
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.